Listed

Advanced Drainage Systems, Inc.: Form 10-Q for the period ended Sep 30, 2025

Filed with the SEC on Nov 6, 2025 and accepted by EDGAR at Nov 6, 2025, 16:02 ET.

Share

Management's discussion and analysis

As filed, 29,570 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Unless the context otherwise indicates or requires, as used in this Quarterly Report on Form 10-Q (“Form 10-Q”), the terms “we,” “our,” “us,” “ADS” and the “Company” refer to Advanced Drainage Systems, Inc. and its directly- and indirectly-owned subsidiaries as a combined entity, except where it is clear that the terms mean only Advanced Drainage Systems, Inc. exclusive of its subsidiaries. We consolidate our joint ventures for purposes of GAAP, except for our South American Joint Venture.

Our fiscal year begins on April 1 and ends on March 31. Unless otherwise noted, references to “year” pertain to our fiscal year. For example, 2026 refers to fiscal 2026, which is the period from April 1, 2025 to March 31, 2026.

The following discussion and analysis of the financial condition and results of our operations should be read in conjunction with our Condensed Consolidated Financial Statements and related footnotes included elsewhere in this Form 10-Q and with the audited Consolidated Financial Statements included in our Fiscal 2025 Form 10-K, as filed with the Securities and Exchange Commission (the “SEC”) on May 15, 2025. In addition to historical condensed consolidated financial information, the following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. This discussion contains forward-looking statements that are based on the beliefs of our management, as well as assumptions made by, and information currently available to, our management. Our actual results could differ materially from those discussed in the forward-looking statements. For more information, see the section entitled “Forward-Looking Statements.”

Overview

ADS is the leading manufacturer of innovative water management solutions in the stormwater and onsite septic wastewater industries, providing superior drainage solutions for use in the construction and agriculture marketplaces. Our innovative products, for which we hold many patents, are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. We have established a leading position in many of these end markets by leveraging our national sales and distribution platform, industry-acclaimed engineering support, overall product breadth and scale plus manufacturing excellence.

Executive Summary

Second Quarter Fiscal 2026 Results

  • Net sales increased 8.7% to $850.4 million
  • Net income increased 19.3% to $156.5 million
  • Net income per diluted share increased 19.2% to $1.99
  • Adjusted EBITDA, a non-GAAP measure, increased 17.1% to $287.5 million

Net sales increased $67.8 million, or 8.7%, to $850.4 million, as compared to $782.6 million in the prior year quarter. Domestic Pipe sales increased $6.7 million, or 1.6%, to $413.0 million. Domestic Allied Products & Other sales increased $22.9 million, or 13.0%, to $199.0 million. Infiltrator sales increased $36.1 million, or 25.2%, to $179.7 million. The overall increase in domestic Net sales was primarily driven by acquisitions, as well as growth in the non-residential and residential construction end markets. International sales increased $2.1 million, or 3.7%, to $58.7 million.

Gross profit increased $46.2 million, or 15.7%, to $340.1 million as compared to $293.9 million in the prior year. The increase in gross profit is primarily driven by volume growth, favorable price/cost, and favorable mix of Allied products and Infiltrator.

Selling, general and administrative expenses increased $25.1 million, or 26.7% to $119.2 million, as compared to $94.1 million in the prior year. As a percentage of Net sales, Selling, general and administrative expenses increased to 14.0% as compared to 12.0% in the prior year, primarily driven by the acquisition of Orenco, as well as transaction costs associated with the acquisition of NDS.

Adjusted EBITDA, a non-GAAP measure, increased $42.0 million, or 17.1%, to $287.5 million, as compared to $245.6 million in the prior year. As a percentage of Net sales, Adjusted EBITDA was 33.8% as compared to 31.4% in the prior year.

Year-to-date Fiscal 2026 Results

  • Net sales increased 5.2% to $1,680.3 million
  • Net income increased 2.4% to $300.6 million
  • Net income per diluted share increased 2.7% to $3.83
  • Adjusted EBITDA, a non-GAAP measure, increased 8.6% to $565.7 million

Net sales increased $82.3 million, or 5.2%, to $1,680.3 million, as compared to $1,597.9 million in the prior year. Domestic Pipe sales decreased $4.2 million to $828.6 million. Domestic Allied Products & Other sales increased $26.4 million, or 7.3%, to $386.5 million. Infiltrator sales increased $67.2 million, or 23.1%, to $358.1 million. The overall increase in domestic net sales was primarily driven by growth in the core non-residential and residential construction end markets. International sales decreased $7.1 million, or 6.2%, to $107.1 million.

Gross profit increased $44.2 million, or 7.1%, to $670.6 million as compared to $626.4 million in the prior year. The increase in gross profit is primarily driven by favorable volume, price/cost and mix of construction market and Infiltrator sales, partially offset by unfavorable fixed cost absorption as well as the mix impact from the inclusion of Orenco.

Selling, general and administrative expenses increased $35.0 million, or 18.6% to $223.2 million, as compared to $188.2 million. As a percentage of Net sales, Selling, general and administrative expense increased to 13.3% as compared to 11.8% in the prior year the acquisition of Orenco, as well as transaction costs associated with the acquisition of NDS.

Adjusted EBITDA, a non-GAAP measure, increased $44.7 million, or 8.6%, to $565.7 million, as compared to $521.0 million in the prior year. As a percentage of Net sales, Adjusted EBITDA was 33.7% as compared to 32.6% in the prior year.

Results of Operations

Comparison of the Three Months Ended September 30, 2025 to the Three Months Ended September 30, 2024

The following table summarizes our operating results as a percentage of Net sales that have been derived from our Condensed Consolidated Financial Statements for the periods presented. We believe this presentation is useful to investors in comparing historical results.

(In thousands)

Consolidated Statements of Operations data: For the Three Months Ended September 30, 2025 2024
Net sales $850,381 100.0% $782,610 100.0%
Cost of goods sold 510,249 60.0 488,669 62.4
Gross profit 340,132 40.0 293,941 37.6
Selling, general and administrative 119,224 14.0 94,132 12.0
(Gain) loss on disposal of assets and costs from exit and disposal activities (15,926) (1.9) 617 0.1
Intangible amortization 13,539 1.6 11,816 1.5
Income from operations 223,295 26.3 187,376 23.9
Interest expense 23,116 2.7 23,156 3.0
Interest income and other, net (8,012) (0.9) (6,956) (0.9)
Income before income taxes 208,191 24.5 171,176 21.9
Income tax expense 52,399 6.2 40,920 5.2
Equity in net income of unconsolidated affiliates (708) (0.1) (918) (0.1)
Net income 156,500 18.4 131,174 16.8
Less: net income attributable to noncontrolling interest 483 0.1 792 0.1
Net income attributable to ADS $156,017 18.3% $130,382 16.7%

Net sales - The following table presents Net sales to external customers by reportable segment for the three months ended September 30, 2025 and 2024.

(Amounts in thousands)

2025 2024 $ Variance % Variance
Pipe $413,049 $406,378 $6,671 1.6%
Infiltrator 179,716 143,598 36,118 25.2
International 58,657 56,553 2,104 3.7
Allied Products & Other 198,959 176,081 22,878 13.0
Total Consolidated $850,381 $782,610 $67,771 8.7%

- 22 -

Our consolidated Net sales for the three months ended September 30, 2025 increased by $67.8 million, or 8.7%, compared to the same period in fiscal 2025. The overall increase in Domestic Pipe Net sales was primarily driven by volume of the non-residential construction market. Net sales of $26.4 million of Orenco and demand in the residential market drove the increase in Net sales for Infiltrator. Allied Products & Other increased due to demand in the residential and non-residential construction markets.

Cost of goods sold and Gross profit - The following table presents gross profit by reportable segment for the three months ended September 30, 2025 and 2024.

(Amounts in thousands)

2025 2024 $ Variance % Variance
Pipe $109,682 $91,276 $18,406 20.2%
Infiltrator 95,843 85,709 10,134 11.8
International 15,697 15,871 (174) (1.1)
Allied Products & Other 118,799 101,725 17,074 16.8
Intersegment eliminations 111 (640) 751 (117.3)
Total gross profit $340,132 $293,941 $46,191 15.7%

Our consolidated Cost of goods sold for the three months ended September 30, 2025 increased by $21.6 million, or 4.4%, and our consolidated Gross profit increased by $46.2 million, or 15.7%, compared to the same period in fiscal 2025. The increase in gross profit for Domestic Pipe is primarily driven by favorable material costs, partially offset by manufacturing and transportation costs. The increase in gross profit for Infiltrator was primarily driven by Orenco.

Selling, general and administrative expenses

(Amounts in thousands)

Three Months Ended September 30, 2025 2024
Selling, general and administrative expenses $119,224 $94,132
% of Net sales 14.0% 12.0%

Selling, general and administrative expenses for the three months ended September 30, 2025 increased $25.1 million from the same period in fiscal 2025 and as a percentage of Net sales, increased by 2.0%. The increase in Selling, general and administrative expenses was primarily due to realignment expenses of $5.5 million, transaction costs of $9.3 million and the operating expenses of Orenco.

(Gain) loss on disposal of assets and costs from exit and disposal activities - The gain on disposal in fiscal 2026 was due to the sale of a property held-for-sale partially offset by exit and disposal activities. See “Note 2. Restructuring and (Gain) Loss on Disposal of Assets and Costs from Exit and Disposal Activities” for additional information.

Income tax expense - The following table presents the effective tax rates for the periods presented:

Three Months Ended September 30, 2025 2024
Effective tax rate 25.2% 23.9%

The change in the effective tax rate for the three months ended September 30, 2025 was primarily driven by the decrease of the discrete income tax benefit related to the stock-based compensation windfall and the additional tax expense recorded to adjust prior quarter income tax expense to the annual effective tax rate. See “Note 11. Income Taxes” for additional information.

Comparison of the Six Months Ended September 30, 2025 to the Six Months Ended September 30, 2024

The following table summarizes our operating results as a percentage of Net sales that have been derived from our Condensed Consolidated Financial Statements for the periods presented. We believe this presentation is useful to investors in comparing historical results.

(In thousands)

Consolidated Statements of Operations data: For the Six Months Ended September 30, 2025 2024
Net sales $1,680,261 100.0% $1,597,946 100.0%
Cost of goods sold 1,009,691 60.1 971,551 60.8
Gross profit 670,570 39.9 626,395 39.2
Selling, general and administrative 223,185 13.3 188,184 11.8
(Gain) loss on disposal of assets and costs from exit and disposal activities (8,902) (0.5) 909 0.1
Intangible amortization 27,246 1.6 23,711 1.5
Income from operations 429,041 25.5 413,591 25.9
Interest expense 46,145 2.7 45,980 2.9
Interest income and other, net (14,717) (0.9) (14,072) (0.9)
Income before income taxes 397,613 23.7 381,683 23.9
Income tax expense 99,073 5.9 90,806 5.7
Equity in net income of unconsolidated affiliates (2,051) (0.1) (2,619) (0.2)
Net income 300,591 17.9 293,496 18.4
Less: net income attributable to noncontrolling interest 652 — 1,712 0.1
Net income attributable to ADS $299,939 17.9% $291,784 18.3%

Net sales - The following table presents Net sales to external customers by reportable segment for the six months ended September 30, 2025 and 2024.

(Amounts in thousands)

2025 2024 $ Variance % Variance
Pipe $828,587 $832,766 $(4,179) (0.5)%
Infiltrator 358,069 290,900 67,169 23.1
International 107,148 114,258 (7,110) (6.2)
Allied Products & Other 386,457 360,022 26,435 7.3
Total Consolidated $1,680,261 $1,597,946 $82,315 5.2%

Our consolidated Net sales for the six months ended September 30, 2025 increased by $82.3 million, or 5.2%, compared to the same period in fiscal 2025. The overall decrease in Domestic Pipe Net sales was primarily driven by lower demand in the residential and infrastructure end markets partially offset by improved demand in the non-residential construction market. Net sales for Infiltrator were also driven by volume in the residential market and the acquisition of Orenco. For the international segment, the decrease was driven by decreased volume. Allied Products & Other increased due to demand in the residential and non-residential construction markets.

Cost of goods sold and Gross profit - The following table presents gross profit by reportable segment for the six months ended September 30, 2025 and 2024.

(Amounts in thousands)

2025 2024 $ Variance % Variance
Pipe $219,187 $212,058 $7,129 3.4%
Infiltrator 193,554 172,316 21,238 12.3
International 28,093 34,168 (6,075) (17.8)
Allied Products & Other 230,381 209,463 20,918 10.0
Intersegment eliminations (645) (1,610) 965 (59.9)
Total gross profit $670,570 $626,395 $44,175 7.1%

- 24 -

Our consolidated Cost of goods sold for the six months ended September 30, 2025 increased by $38.1 million, or 3.9%, and our consolidated Gross profit increased by $44.2 million, or 7.1%, compared to the same period in fiscal 2025. The increase in gross profit for Domestic Pipe is primarily driven by favorable material cost partially offset by unfavorable fixed cost absorption. The increase in gross profit for Infiltrator was driven by volume and the acquisition of Orenco. For the International segment, the decrease was driven by decreased volume.

Selling, general and administrative expenses

(Amounts in thousands)

Six Months Ended September 30, 2025 2024
Selling, general and administrative expenses $223,185 $188,184
% of Net sales 13.3% 11.8%

Selling, general and administrative expenses for six months ended September 30, 2025 increased $35.0 million from the same period in fiscal 2025 and as a percentage of Net sales, increased by 1.5%. The increase in Selling, general and administrative expenses was also due to realignment expenses of $8.4 million, transaction costs of $10.1 million and operating expenses for Orenco.

(Gain) loss on disposal of assets and costs from exit and disposal activities - The gain on disposal in fiscal 2026 was due to the sale of properties held-for-sale partially offset by exit and disposal activities. See “Note 2. Restructuring and Gain (Loss) on Disposal of Assets and Costs from Exit and Disposal Activities” for additional information.

Income tax expense - The following table presents the effective tax rates for the six months ended September 30, 2025 and 2024.

Six Months Ended September 30, 2025 2024
Effective tax rate 24.9% 23.8%

The change in the effective tax rate for the six months ended September 30, 2025 was primarily driven by the decrease of the discrete income tax benefit related to the stock-based compensation windfall. See “Note 11. Income Taxes” for additional information.

Adjusted EBITDA and Adjusted EBITDA Margin - Adjusted EBITDA and Adjusted EBITDA Margin, which are non-GAAP financial measures, have been presented in this Form 10-Q as supplemental measures of financial performance that are not required by, or presented in accordance with GAAP and should not be considered as alternatives to net income as measures of financial performance or cash flows from operations or any other performance measure derived in accordance with GAAP. We calculate Adjusted EBITDA as net income before interest, income taxes, depreciation and amortization, stock-based compensation expense, non-cash charges and certain other expenses. We calculate Adjusted EBITDA Margin as Adjusted EBITDA divided by Net sales.

Adjusted EBITDA and Adjusted EBITDA Margin are included in this Form 10-Q because they are key metrics used by management and our board of directors to assess our consolidated financial performance. These non-GAAP financial measures are frequently used by analysts, investors and other interested parties to evaluate companies in our industry. In addition to covenant compliance and executive performance evaluations, we use these non-GAAP financial measures to supplement GAAP measures of performance to evaluate the effectiveness of our consolidated business strategies, to make budgeting decisions and to compare our performance against that of other peer companies using similar measures. We use Adjusted EBITDA Margin to evaluate our ability to generate profitable sales.

Adjusted EBITDA and Adjusted EBITDA Margin contain certain other limitations, including the failure to reflect our cash expenditures, cash requirements for working capital needs, cash expenditures to replace assets being depreciated and amortized and interest expense, or the cash requirements necessary to service interest on principal payments on our indebtedness. In evaluating Adjusted EBITDA and Adjusted EBITDA Margin, you should be aware that in the future we will incur expenses that are the same as or similar to some of the adjustments in this presentation, such as stock-based compensation expense, derivative fair value adjustments, and foreign currency transaction losses. Management compensates for these limitations by relying on our GAAP results and using non-GAAP measures on a supplemental basis.

The following table presents a reconciliation of Adjusted EBITDA to Net income, the most comparable GAAP measure, for each of the periods presented.

(In thousands)

Three Months Ended September 30, 2025 2024 Six Months Ended September 30, 2025 2024
Net income $156,500 $131,174 $300,591 $293,496
Depreciation and amortization 54,693 44,807 104,921 85,905
Interest expense 23,116 23,156 46,145 45,980
Income tax expense 52,399 40,920 99,073 90,806
EBITDA 286,708 240,057 550,730 516,187
Restructuring and realignment expense(a) 7,171 — 15,966 —
(Gain) loss on disposal of assets (17,644) 617 (16,446) 909
Stock-based compensation expense 8,577 6,983 16,981 13,960
Transaction costs(b) 9,317 2,685 10,124 2,695
Interest income (7,340) (7,368) (12,745) (13,933)
Other adjustments(c) 743 2,576 1,089 1,230
Adjusted EBITDA $287,532 $245,550 $565,699 $521,048
Adjusted EBITDA Margin 33.8% 31.4% 33.7% 32.6%

(a) Includes costs associated with closure of one recycling facility, one offsite storage location and one distribution yard, as well as professional fees incurred in connection with supporting enterprise-wide restructuring and realignment initiatives. Excludes gain on sale of properties previously held-for-sale and equipment. See “Note 2. Restructuring and Gain (Loss) on Disposal of Assets and Costs from Exit and Disposal Activities” for additional information.

(b) Represents expenses recorded related to legal, accounting and other professional fees incurred in connection with business or asset acquisitions and dispositions.

(c) Includes derivative fair value adjustments, foreign currency transaction (gains) losses, legal settlements, and the proportionate share of interest, income taxes, depreciation and amortization related to the South American Joint Venture, which is accounted for under the equity method of accounting and executive retirement expense.

Liquidity and Capital Resources

Historically, we have funded our operations through internally generated cash flow supplemented by debt financings, equity issuance and finance and operating leases. These sources have been sufficient historically to fund our primary liquidity requirements, including working capital, capital expenditures, debt service and dividend payments for our common stock. From time to time, we may explore additional financing methods and other means to raise capital. There can be no assurance that any additional financing will be available to us on acceptable terms or at all.

Free Cash Flow - Free cash flow is a non-GAAP financial measure that comprises cash flow from operations less capital expenditures and is used by management and our Board of Directors to assess our ability to generate cash. Accordingly, free cash flow has been presented as a supplemental measure of liquidity that is not required by, or presented in accordance with GAAP, because management believes that free cash flow provides useful information to investors and others in understanding and evaluating our ability to generate cash flow from operations after capital expenditures. Free cash flow is not a GAAP measure of our liquidity and should not be considered as an alternative to cash flow from operating activities as a measure of liquidity or any other liquidity measure derived in accordance with GAAP. Our measure of free cash flow is not necessarily comparable to other similarly titled captions of other companies due to different methods of calculation.

The following table presents a reconciliation of free cash flow to cash provided by operating activities, the most comparable GAAP measure, for each of the periods presented:

(Amounts in thousands)

Six Months Ended September 30, 2025 2024
Net cash provided by operating activities $509,843 $350,326
Capital expenditures (111,018) (112,182)
Free Cash Flow $398,825 $238,144

- 26 -

The following table presents key liquidity metrics utilized by management including the leverage ratio which is calculated as net debt divided by the trailing twelve months Adjusted EBITDA:

(Amounts in thousands)

September 30, 2025
Total debt (debt and finance lease obligations) $1,431,004
Cash 812,862
Net debt (total debt less cash) 618,142
Leverage Ratio 0.7

The following table summarizes our available liquidity for the period presented:

(Amounts in thousands)

September 30, 2025
Revolver capacity $600,000
Less: outstanding borrowings —
Less: letters of credit (10,133)
Revolver available liquidity $589,867

In addition to the available liquidity above, we have the ability to borrow up to $1.3 billion under our Senior Secured Credit Facility, subject to leverage ratio restrictions.

As of September 30, 2025, we had $26.2 million in cash that was held by our foreign subsidiaries, including $15.8 million held by our Canadian subsidiaries. We continue to evaluate our strategy regarding foreign cash, but our earnings in foreign subsidiaries still remain indefinitely reinvested, except for Canada. We plan to repatriate earnings from Canada and believe that there will be no additional tax costs associated with the repatriation of such earnings other than any potential non-U.S. withholding taxes.

Working Capital and Cash Flows

As of September 30, 2025, we had $1,402.7 million in liquidity, including $812.9 million of cash and $589.9 million in borrowings available under our Revolving Credit Agreement, net of outstanding letters of credit. We believe that our cash on hand, together with the availability of borrowings under our Credit Agreement and other financing arrangements and cash generated from operations, will be sufficient to meet our working capital requirements, anticipated capital expenditures, and scheduled principal and interest payments on our indebtedness for at least the next twelve months.

As disclosed in “Note 3. Acquisitions”, we expect to fund our acquisition of NDS in the fourth fiscal quarter of 2026 with cash on hand and capacity on our existing Revolving Credit Facility.

Working Capital - Working capital increased to $1,192.0 million as of September 30, 2025, from $926.4 million as of March 31, 2025. The increase in working capital is primarily due to increased cash on hand and the seasonality of accounts receivable offset by changes in inventory and accrued liabilities due to the timing of tax and rebate payments.

(Amounts in thousands)

Six Months Ended September 30, 2025 2024
Net cash provided by operating activities $509,843 $350,326
Net cash used in investing activities (105,343) (111,542)
Net cash used in financing activities (55,853) (114,640)

Operating Cash Flows - Cash flows from operating activities increased $159.5 million during the six months ended September 30, 2025 primarily driven by changes in working capital.

Investing Cash Flows - Cash flows used in investing activities during the six months ended September 30, 2025 decreased by $6.2 million compared to the same period in fiscal 2025. The decrease in cash used in investing activities was due to the proceeds from the sale of properties held-for-sale offset by the acquisition of River Valley Pipe.

Capital expenditures totaled $111.0 million and $112.2 million for the six months ended September 30, 2025 and 2024, respectively. Our capital expenditures for the six months ended September 30, 2025 were used primarily to support facility expansions, equipment replacements and technology improvement initiatives. We also acquired $33.1 million of property, plant and equipment under finance leases, which includes material handling transportation equipment to update our fleet of forklifts, trucks and trailers.

We currently anticipate that we will make capital expenditures of approximately $200 million to $225 million in fiscal year 2026, including approximately $80 million of open orders as of September 30, 2025. Such capital expenditures are expected to be financed using funds generated by operations.

Financing Cash Flows - During the six months ended September 30, 2025, cash used in financing activities included $28.1 million of dividend payments, $17.2 million of payments of finance lease obligations and $6.7 million for shares withheld for tax purposes.

During the six months ended September 30, 2024, cash used in financing activities included the repurchase of common stock of $69.9 million, $24.9 million of dividend payments, $11.8 million of payments of finance lease obligations and $10.6 million for shares withheld for tax purposes.

Financing Transactions - There have been no changes in our debt disclosures from those disclosed in “Liquidity and Capital Resources” in our Fiscal 2025 Form 10-K. We are in compliance with our debt covenants as of September 30, 2025.

As of September 30, 2025, we have $409.8 million of debt under our Term Loan facility maturing within twelve months on its scheduled maturity. We have classified this debt as long-term debt as we have the intent and the ability to refinance these borrowings on a long-term basis as supported by the available capacity under the Revolving Credit Facility.

Off-Balance Sheet Arrangements

Excluding the guarantees of 50% of certain debt of our unconsolidated South American Joint Venture as further discussed in “Note 8. Related Party Transactions” to the Condensed Consolidated Financial Statements, we do not have any other off-balance sheet arrangements. As of September 30, 2025, our South American Joint Venture had no outstanding debt subject to our guarantees. We do not believe that this guarantee will have a current or future effect on our financial condition, results of operations, liquidity or capital resources.

Critical Accounting Policies and Estimates

There have been no changes in critical accounting policies from those disclosed in “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Fiscal 2025 Form 10-K, except as disclosed in “Note 1. Background and Summary of Significant Accounting Policies.”

Market risk

As filed, 1,290 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

We are subject to various market risks, primarily related to changes in interest rates, credit, raw material supply prices and, to a lesser extent, foreign currency exchange rates. Our financial position, results of operations or cash flows may be negatively impacted in the event of adverse movements in the respective market rates or prices in each of these risk categories. Our exposure in each category is limited to those risks that arise in the normal course of business, as we do not engage in speculative, non-operating transactions. Our exposure to market risk has not materially changed from what we previously disclosed in Part II. Item 7A. “Quantitative and Qualitative Disclosures about Market Risk” of our Fiscal 2025 Form 10-K except as disclosed below.

Interest Rate Risk - We are subject to interest rate risk associated with our bank debt. A 1.0% increase in interest rates on our variable-rate debt would increase our annual forecasted interest expense by approximately $4.1 million based on our borrowings as of September 30, 2025. Assuming the Revolving Credit Facility is fully drawn, each 1.0% increase or decrease in the applicable interest rate would change our interest expense by approximately $10.1 million, for the twelve months ended September 30, 2025.

Controls and procedures

As filed, 1,723 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures - The Company’s Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”) are responsible for evaluating the effectiveness of our disclosure controls and procedures as defined in the Securities Exchange Act of 1934, as amended (the “Exchange Act”), rules 13a-15(e) and 15d-15(e). The Company’s disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed in the Company’s reports under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Company’s CEO and CFO, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

Based on the evaluation of our disclosure controls and procedures, our CEO and CFO concluded that the Company’s disclosure controls and procedures were effective as of the end of the period covered by this report.

Changes in Internal Control over Financial Reporting - There were no changes in the Company’s internal control over financial reporting as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act that occurred during the three months ended September 30, 2025 that has materially affected, or is reasonably likely to materially affect, internal control over financial reporting.

Risk factors

As filed, 553 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Important risk factors that could affect our operations and financial performance, or that could cause results or events to differ from current expectations, are described in “Part I, Item 1A — Risk Factors” of our Fiscal 2025 Form 10-K. These factors are further supplemented by those discussed in “Part II, Item 7A — Quantitative and Qualitative Disclosures about Market Risk” of our Fiscal 2025 Form 10-K and in “Part I, Item 3 — Quantitative and Qualitative Disclosures about Market Risk” and “Part II, Item 1 — Legal Proceedings” of this Form 10-Q.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2025-07-01 to 2025-09-30$850.4mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2025-04-01 to 2025-09-30$1.68bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Gross profit3 months2025-07-01 to 2025-09-30$340.1mus-gaap:GrossProfit
Gross profit6 months2025-04-01 to 2025-09-30$670.6mus-gaap:GrossProfit
Operating income3 months2025-07-01 to 2025-09-30$223.3mus-gaap:OperatingIncomeLoss
Operating income6 months2025-04-01 to 2025-09-30$429.0mus-gaap:OperatingIncomeLoss
Income tax3 months2025-07-01 to 2025-09-30$52.4mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2025-04-01 to 2025-09-30$99.1mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-07-01 to 2025-09-30$156.0mus-gaap:NetIncomeLoss
Net income6 months2025-04-01 to 2025-09-30$299.9mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-07-01 to 2025-09-30$1.99us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2025-04-01 to 2025-09-30$3.83us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-07-01 to 2025-09-30$2.01us-gaap:EarningsPerShareBasic
Basic EPS6 months2025-04-01 to 2025-09-30$3.86us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-07-01 to 2025-09-3078,310,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2025-04-01 to 2025-09-3078,240,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2025-04-01 to 2025-09-30$509.8mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2025-04-01 to 2025-09-30$111.0mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2025-04-01 to 2025-09-30$28.1mus-gaap:PaymentsOfDividendsCommonStock
Share repurchases6 months2025-04-01 to 2025-09-30$0us-gaap:PaymentsForRepurchaseOfCommonStock
Cash and equivalentsAt period end2025-09-30$812.9mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2025-09-30$1.67bnus-gaap:AssetsCurrent
Total assetsAt period end2025-09-30$4.08bnus-gaap:Assets
Current liabilitiesAt period end2025-09-30$480.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2025-09-30$2.15bnus-gaap:Liabilities
Long-term debtAt period end2025-09-30$1.25bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2025-09-30$8.7mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2025-09-30$1.83bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001604028-25-000043. Last ingested by Listed: Nov 14, 2026, 20:53 ET. Listed shows no prices and gives no investment advice.